SecBot SecBot
6-K ·Filed Nov 12, 2026

AKZOY

AKZO NOBEL NV
NEUTRAL
Impact 4/10
Horizonmonths Processed4d 19h ago SEC0000950103-26-017304
Notable filing: 6-K
Actionable Insight • Neutral

The CMA Phase 1 decision is a procedural step; the key question is whether the proposed remedy will satisfy the CMA in Phase 2. Monitor for the CMA's Phase 2 decision and any conditions imposed. The merger timeline to early 2027 remains intact.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$23.19
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.04%
T+1 · $23.18
Vs SPY
+0.32%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $23.19entry
  2. T+1 · 4d ago −0.04%α +0.32% · $23.18
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AkzoNobel and Axalta are considering the UK CMA's Phase 1 decision on their proposed merger, which identified competition concerns only in UK vehicle refinish coatings. The companies plan to address this with the same remedy package already agreed with the European Commission, involving divestment of AkzoNobel's European VR coatings business. The merger is expected to close by early 2027, creating a combined company with approximately $17 billion in revenue.

Key Facts

  • UK CMA Phase 1 decision identified competition concerns solely in UK vehicle refinish coatings
  • AkzoNobel and Axalta will propose the same remedy as agreed with the European Commission: divestment of AkzoNobel's European VR coatings business including UK
  • Companies remain confident the merger will complete by early 2027
  • Combined company would have approximately $17 billion in revenue

Financial Impact

No financial terms disclosed; merger consideration was set in prior filings (June 2026). The remedy involves divestment of a business unit, but no value stated.

revenue

Risk Factors

  • CMA may not accept the proposed remedy in Phase 2, potentially requiring additional divestitures or blocking the merger
  • Merger completion could be delayed beyond early 2027 if regulatory hurdles arise
  • The divestment of the European VR coatings business may reduce combined revenue and synergies

Market Snapshot

Exchange
OTC
Analyst Consensus
70% bullish (23 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0000950103-26-017304
Document: dp256705_6k.htm0000950103-26-017304
Document: 0000950103-26-017304-index-headers.html0000950103-26-017304
Document: 0000950103-26-017304-index.html0000950103-26-017304
Document: 0000950103-26-017304.txt0000950103-26-017304
Earnings Context (Synthetic; results releases only)0000950103-26-017304

Track record

14 reports on AKZOY

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +7.29% at T+20 after the Oct 5, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 4/10 Viewing Entry $23.19 to $23.18 Now $22.90 −1.25% ▼ −0.04% +0.32% vs SPY
  2. Nov 6, 202610d ago 6-K Bullish 6/10 Entry $23.30 to $23.97 Now $22.90 −1.72% ▲ +2.88% +0.51% vs SPY
  3. Oct 21, 202626d ago 6-K Neutral 5/10 No price data
  4. Oct 21, 202626d ago 6-K Neutral 4/10 No price data
  5. Oct 21, 202626d ago 6-K Neutral 4/10 Entry $22.83 to $22.59 Now $22.90 +0.31% ▼ −1.05% +0.13% vs SPY
  6. Oct 16, 20264w ago 6-K Neutral 4/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
  7. Oct 15, 20264w ago 6-K Neutral 3/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
  8. Oct 5, 20266w ago 6-K Bullish 6/10 Entry $21.53 to $21.87 Now $22.90 +6.36% ▲ +1.58% +1.03% vs SPY
  9. Aug 31, 202611w ago 6-K Neutral 3/10 Entry $23.91 to $23.07 Now $22.90 −4.22% ▼ −3.51% −2.83% vs SPY
  10. Jul 23, 202616w ago 6-K Neutral 3/10 Entry $21.28 to $21.93 Now $22.90 +7.61% ▲ +3.05% +2.95% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 7h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026